Clinical significance of platelet count and its dynamic change in patients with acute-on-chronic liver failure
-
摘要:
目的肝衰竭患者往往存在严重的血小板减少现象。对慢加急性肝衰竭(ACLF)患者血小板的动态变化进行监测分析,探讨血小板水平及其变化与患者预后的关系,并分析血小板减少的原因。方法收集2014年9月-2016年9月于首都医科大学附属北京佑安医院住院的54例ACLF患者的临床资料。血小板由全自动血常规分析仪检测获得,促血小板生成素(TPO)水平采用ELISA方法检测获得。正态分布的计量资料2组间比较采用t检验;非正态分布的计量资料2组间比较采用Mann-Whitney U检验;计数资料组间比较采用χ2检验。预后相关参数采用单因素及多因素logistic回归分析;应用受试者工作特征曲线(ROC曲线)分析血小板计数变化对肝衰竭的诊断价值。结果 ACLF患者出院时死亡18例,病死率为33.3%。ACLF患者基线血小板为80.0(36.0334.0)×109/L,较正常值明显下降。出院前血小板下降幅度在死亡组显著大于存活组[(-43.4±58.9)×109/L vs(-11.5±29.1)×109/L,t=-2.827,P=0.041]。以血小板变化-27.5×109/L为cut...
Abstract:Objective To investigate the dynamic change of platelets in patients with acute-on-chronic liver failure (ACLF) , the association of platelet count and its change with patients' prognosis, and the cause of thrombocytopenia, since severe thrombocytopenia is often seen in patients with liver failure.Methods A total of 54 patients with ACLF who were hospitalized in Beijing You' an Hospital, Capital Medical University, from September 2014 to September 2016 were enrolled, and their clinical data were collected.An automatic blood analyzer was used to measure platelet count, and ELISA was used to measure the level of thrombopoietin (TPO) .The t-test was used for comparison of normally distributed continuous data between two groups, and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups; the chi-square test was used for comparison of categorical data between groups.The univariate and multivariate logistic regression analyses were used for prognostic parameters, and the receiver operating characteristic (ROC) curve was used to analyze the value of the change in platelet count in the diagnosis of liver failure.Results A total of 18 ACLF patients died before discharge, resulting in a mortality rate of 33.3%.These patients had a mean platelet count of 80.0 × 109/L [range (36.0-334.0) ×109/L], which was significantly lower than the normal value.The death group had a significantly greater reduction in platelet count than the survival group [ (-43.4 ± 58.9) × 109/L vs (-11.5 ± 29.1) × 109/L, t =-2.827, P = 0.041].With -27.5 × 109/L as the cut-off value of the change in platelet count, there was a significant difference in mortality rate between the platelet count change >-27.5 × 109/L group and the platelet count change ≤-27.5 × 109/L group (22.2% vs 72.2%, χ2= 12.623, P < 0.01) .The univariate analysis showed that platelet change, prothrombin time activity, and fasting blood glucose were influencing factors for patients' prognosis, and the multivariate analysis showed that platelet change was an independent influencing factor for the prognosis of ACLF patients, with an area under the ROC curve of0.743.The plasma level of TPO was measured for 24 patients, among whom 8 died before discharge, resulting in a mortality rate of 33.3%.There was no significant difference in the level of TPO between the survival group and the death group (91.8 ± 39.8 pg/ml vs 93.3 ± 46.5 pg/ml, t = 0, P = 0.938) .Conclusion Baseline platelet count in ACLF patients is significantly lower than the normal value.The reduction in platelet count is an independent risk factor for death before discharge in ACLF patients.Thrombocytopenia may not be associated with the reduction in TPO.
-
Key words:
- liver failure /
- thrombocytopenia /
- thrombopoietin /
- prognosis
-
[1]QAMAR AA, GRACE ND, GROSZMANN RJ, et al.Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis[J].Clin Gastroenterol Hepatol, 2009, 7 (6) :689-695. [2]GHANY MG, LOK AS, EVERHART JE, et al.Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C[J].Gastroenterology, 2010, 138 (1) :136-146. [3]GUSTOT T, FERNANDEZ J, GARCIA E, et al.Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis[J].Hepatology, 2015, 62 (1) :243-252. [4]LEI Q, MENG ZJ.Search progress of acute-on-chronic liver failure[J].China Med Herald, 2016, 13 (14) :45-48. (in Chinese) 雷青, 孟忠吉.慢加急性肝衰竭的研究进展[J].中国医药导报, 2016, 13 (14) :45-48. [5]MA Z, WU Y.Current status of liver failure treatment[J].J Clin Hepatol, 2016, 32 (9) :1668-1672. (in Chinese) 马臻, 乌云.肝衰竭的治疗现状[J].临床肝胆病杂志, 2016, 32 (9) :1668-1672. [6]LI WY, ZHANG MX, QI TT.The potential factors contributing to thrombocytopenia in acute on chronic liver failure patients[J].Chin Hepatol, 2015, 20 (6) :457-461. (in Chinese) 李文燕, 张明霞, 祁婷婷, 等.慢加急性肝衰竭患者血小板减少的可能原因[J].肝脏, 2015, 20 (6) :457-461. [7]PECK-RADOSAVLJEVIC M, WICHLAS M, ZACHERL J, et al.Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production[J].Blood, 2000, 95 (3) :795-801. [8]HITCHCOCK IS, KAUSHANSKY K.Thrombopoietin from beginning to end[J].Br J Haematol, 2014, 165 (2) :259-268. [9]GANGIREDDY VG, KANNEGANTI PC, SRIDHAR S, et al.Management of thrombocytopenia in advanced liver disease[J].Can J Gastroenterol Hepatol, 2014, 28 (10) :558-564. [10]SAKAI K, IWAO T, OHO K, et al.Propranolol ameliorates thrombocytopenia in patients with cirrhosis[J].J Gastroenterol, 2002, 37 (2) :112-118. [11]OLARIU M, OLARIU C, OLTEANU D.Thrombocytopenia in chronic hepatitis C[J].J Gastrointestin Liver Dis, 2010, 19 (4) :381-385. [12]KAJIHARA M, OKAZAKI Y, KATO S, et al.Evaluation of platelet kinetics in patients with liver cirrhosis:similarity to idiopathic thrombocytopenic purpura[J].J Gastroenterol Hepatol, 2007, 22 (1) :112-118. 期刊类型引用(10)
1. 黄秀香,霍明思,李雪,刘金艳,李广丽,叶迎宾,吕广波,党殿杰. RDW-SD、RPR和RLR对原发性胆汁性胆管炎肝硬化失代偿期的评估价值. 重庆医学. 2024(02): 209-213 . 百度学术
2. 李守娟,王丽,周明,吴蓓,王磊,段萌,廖洪帆,胡瑞晴,胡朝霞,朱丽,胡娟. 经选择性血浆分离器行人工肝治疗低血小板计数慢加急性肝衰竭患者的效果及安全性分析. 临床肝胆病杂志. 2024(06): 1191-1195 . 本站查看
3. 巴哈尔古丽·罗克满江,曾钰,吴雪,肖红. 甲胎蛋白和肝细胞生长因子表达水平评估乙肝相关慢加急性肝衰竭患者预后的价值. 热带医学杂志. 2024(06): 829-833 . 百度学术
4. 王璐,许文雄,朱姝,李学俊,陈苑莉,谢婵,彭亮. 人工肝治疗HBV相关慢加急性肝衰竭的血小板计数变化及其影响因素. 临床肝胆病杂志. 2022(05): 1053-1058 . 本站查看
5. 蔡稳,刘通,马广宇,赵文静. APRI联合血小板计数短期变化率对脓毒症相关肝损伤的预测价值. 医学研究杂志. 2022(06): 67-71+77 . 百度学术
6. 谢志伟,陆霭琪,杨可立,陈彬彬,关玉娟,肖光明,李剑萍. 乙型肝炎病毒相关慢加急性肝衰竭患者血清miRNA差异表达谱及其预后预测价值. 肝脏. 2022(08): 853-857 . 百度学术
7. 窦培勋. 血常规和肝功能检查在诊断病毒性肝炎中的应用价值. 实用医技杂志. 2021(07): 892-894 . 百度学术
8. 黄贝贝,宁玲,李文渊,郑晓玮,张玥,江守伟,张振华,李磊. 血浆置换与双重血浆分子吸附系统单用或联合使用治疗HBV 相关慢加急性肝衰竭患者预后预测模型的建立与评估. 临床肝胆病杂志. 2021(12): 2802-2807 . 本站查看
9. 胡辉,黄贝贝,宁玲,江守伟,沈强,刘磊,李磊. HBV相关慢加急性肝衰竭患者短期预后预测模型的建立与评价. 临床肝胆病杂志. 2020(01): 123-127 . 本站查看
10. 冯楠,冯波,邢星敏. 红细胞分布宽度、血小板计数与乳酸水平对慢加急性肝衰竭患者经血浆置换治疗预后评估价值. 临床军医杂志. 2019(03): 320-322 . 百度学术
其他类型引用(11)
-